Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent ...

The Global Liver Institute urges worldwide integration of liver health into diabetes and obesity care as steatotic liver ...

Aging and chronic diseases involve the gradual accumulation of subtle tissue changes over a long period. Therefore, there are ...

Discover a recent study where the authors propose a strategic push to double the diagnostic rate of at-risk MASH by 2030.

Once considered a niche concern, it is now a growing global epidemic affecting more than one in four adults worldwide.

Dapagliflozin, a SGLT2 inhibitor used for type 2 diabetes, alleviates steatohepatitis and fibrosis in patients with ...

Excess fat mass estimated by waist-circumference-to-height ratio predicts the risk of liver damage better than body mass ...